Literature DB >> 9690708

Olanzapine-induced reversible priaprism: a case report.

J M Deirmenjian, S M Erhart, D A Wirshing, B J Spellberg, W C Wirshing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690708     DOI: 10.1097/00004714-199808000-00023

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

1.  Priapism during treatment with olanzapine, quetiapine, and risperidone in a patient with schizophrenia: a case report.

Authors:  Kenan M Penaskovic; Fasiha Haq; Shakeel Raza
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Can Priapism Occur as an Idiosyncratic Reaction to Risperidone?

Authors:  Ömer Şenormanci; Nuray Atasoy; Numan Konuk; Özge Saraçli; Levent Atik
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

Review 3.  Tolerability of atypical antipsychotics.

Authors:  C Stanniland; D Taylor
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

4.  Diagnostic Difficulties and Treatment Challenges of a Young Patient With Severe Acute Psychosis and Complete Recovery.

Authors:  Jagoda Siembida; Saaduddin Mohammed; Mariam Chishty; Luba Leontieva
Journal:  Cureus       Date:  2022-04-01

Review 5.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Treatment of clozapine-induced priapism by goserline acetate injection.

Authors:  Gursharan Lal Kashyap; Jitendra Nayar; Adnan Bashier; Soosamma Varghese
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

7.  Olanzapine-induced Priapism in a Child with Asperger's Syndrome.

Authors:  Hasan Bozkurt; Serkan Şahin
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

8.  Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia.

Authors:  Maria-Ioanna Stefanou; Debora Vittore; Ines Wolz; Stefan Klingberg; Dirk Wildgruber
Journal:  Front Psychiatry       Date:  2020-04-20       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.